carisoprodol has been researched along with Bone Diseases, Developmental in 1 studies
Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blicharski, T | 1 |
| Burdan, F | 1 |
| Małkiewicz, J | 1 |
| Piechota, G | 1 |
1 other study available for carisoprodol and Bone Diseases, Developmental
| Article | Year |
|---|---|
Blockade of reticular formation activity, due to carisoprodol maternal administration, and its effects on rat skeleton development.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Bone Diseases, Developmental; Carisoprodol; Fe | 2002 |